Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection
Authors:ID Hribernik, Nežka, Onkološki inštitut (Author)
ID Požek, Igor, Klinika Golnik (Author)
ID Kern, Izidor, Klinika Golnik (Author)
Files:.pdf PDF - Presentation file, download (969,72 KB)
MD5: 50AE475AF2354BE07010C70D9821B666
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKPBAG - University Clinic of Respiratory and Allergic Diseases Golnik
Abstract:Background. The outcomes of patients with both lung cancer and idiopathic pulmonary fibrosis (IPF) are unfavorable. Therapeutic interventions for lung cancer such as surgery can cause acute exacerbation of IPF (aeIPF). This study aimed to assess the frequency of IPF in a group of patients with early-stage non-small-cell lung cancer (NSCLC) and to report clinical characteristics and outcomes of this cohort of patients. Patients and methods. This observational cohort retrospective study analyzed 641 pathological records of patients after surgical resection of early-stage non-small-cell lung cancer (NSCLC) at University Clinic Golnik from May 2010 to April 2017. Pathological records of NSCLC with coexisting IPF were reviewed. CT scans and biopsy specimens for this group of patients were analyzed by a thoracic radiologist and pathologist, independently. We searched radiological and pathological features of usual interstitial pneumonia (UIP) pattern in this group of patients. We report the clinical characteristics and outcome of this cohort of patients. Results. Out of 641 patients with early-stage NSCLC, only 13 (2.0%) had histologically and radiologically proven coexisting UIP/IPF. Squamous cell carcinoma was the most common type of lung cancer (7/13 patients). The majority of tumors were small size (all being pT1 or pT2), stage I–II (11/13 patients), located in the lower lung lobes (11/13 patients). Almost all patients were current or ex-smokers (11/13 patients). There were two pathologically confirmed fatal cases (15.4%) due to aeIPF in the first two months after radical treatment, one after adjuvant radiotherapy and the other after surgery. Out of 13 patients, one patient had a lung cancer relapse. Conclusions. Frequency of UIP/IPF in surgically treated early stage NSCLC is rather low. Our observational study shows that radical treatment of lung cancer can cause aeIPF with dismal outcome in this group of patients. The standard of care in these mostly elderly patients still remains unresolved.
Keywords:non-small-cell lung cancer, early-stage cancer, idiopathic pulmonary fibrosis, surgery, radiotherapy
Publication status:Published
Publication version:Version of Record
Place of publishing:Slovenija
Publisher:Sciendo
Year of publishing:2019
Number of pages:str. 357-361
Numbering:Vol. 53, no. 3
PID:20.500.12556/DiRROS-12526 New window
UDC:616.2
ISSN on article:1318-2099
DOI:10.2478/raon-2019-0032 New window
COBISS.SI-ID:3298171 New window
Copyright:© 2019 Hribernik Nezka, Pozek Igor, Kern Izidor
Publication date in DiRROS:07.10.2020
Views:1930
Downloads:859
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Radiology and oncology
Shortened title:Radiol. oncol.
Publisher:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 New window

Licences

License:CC BY-NC-ND 3.0, Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
Link:http://creativecommons.org/licenses/by-nc-nd/3.0/
Description:You are free to reproduce and redistribute the material in any medium or format. You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Licensing start date:26.06.2019

Secondary language

Language:Undetermined
Keywords:nedrobnocelični rak pljuč, zgodnji rak, idiopatska pljučna fibroza, kirurgija, radioterapija


Back